These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15255235)

  • 41. Pharmacologic vitreolysis combining the two enzymes plasmin and hyaluronidase.
    Gandorfer A; Kampik A
    Retina; 2005; 25(5):674; author reply 674-5. PubMed ID: 16077373
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of intravitreal dispase on vitreoretinal interface in rabbits.
    Zhu D; Chen H; Xu X
    Curr Eye Res; 2006 Nov; 31(11):935-46. PubMed ID: 17114119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of methylated collagen as a substitute for vitreous and aqueous humor.
    Liang C; Peyman GA; Serracarbassa P; Calixto N; Chow AA; Rao P
    Int Ophthalmol; 1998; 22(1):13-8. PubMed ID: 10090443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinal toxicity of intravitreal tenecteplase in the rabbit.
    Rowley SA; Vijayasekaran S; Yu PK; McAllister IL; Yu DY
    Br J Ophthalmol; 2004 Apr; 88(4):573-8. PubMed ID: 15031179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.
    Sebag J; Ansari RR; Suh KI
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):576-80. PubMed ID: 16941141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment.
    Gad Elkareem AM; Willikens B; Stassen JM; de Smet MD
    Curr Eye Res; 2010 Mar; 35(3):235-41. PubMed ID: 20373883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
    Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution.
    Zeana D; Becker J; Kuckelkorn R; Kirchhof B
    Int Ophthalmol; 1999; 23(1):17-24. PubMed ID: 11008894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery.
    Rizzo S; Pellegrini G; Benocci F; Belting C; Baicchi U; Vispi M
    Retina; 2006 Sep; 26(7):792-6. PubMed ID: 16963853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravitreal autologous plasmin prepared by urokinase for vitreolysis: a pilot study.
    Maleki A; Tohidi-Zand SR; Amirizadeh N; Dehghan-Haghighi J; Zanjani H; Arish M; Salari AM; Mirhosseini SM; Abrishami M
    Eur J Ophthalmol; 2016; 26(1):67-70. PubMed ID: 26044374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lens subluxation after plasmin and SF6 injections in rabbit eyes.
    Wu WC; Liu CH; Wang NK; Chen KJ; Chen TL; Hwang YS; Liao PJ; Li LM; Lai CC
    PLoS One; 2014; 9(11):e112957. PubMed ID: 25397749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
    Chen W; Mo W; Sun K; Huang X; Zhang YL; Song HY
    Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin.
    Schumann RG; Wolf A; Mayer WJ; Compera D; Hagenau F; Ziada J; Kampik A; Haritoglou C
    Am J Ophthalmol; 2015 Oct; 160(4):767-78. PubMed ID: 26133247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocriplasmin for pharmacologic vitreolysis.
    Kuppermann BD
    Retina; 2012 Sep; 32 Suppl 2():S225-8; discussion S228-31. PubMed ID: 22929326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacological vitreolysis.
    Oliveira LB; Meyer CH; Kumar J; Tatebayashi M; Toth CA; Wong F; Epstein DL; McCuen BW
    Curr Eye Res; 2002 Dec; 25(6):333-40. PubMed ID: 12789539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
    Yamamoto N; Ozaki N; Murakami K
    Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.